Designing Nanomedicines for Breast Cancer Therapy

In 2020, breast cancer became the most diagnosed cancer worldwide. Conventional chemotherapies have major side effects due to their non-specific activities. Alternatively, short interfering RNA(siRNA)-carrying nanoparticles (NPs) have a high potential to overcome this non-specificity. Lipid-substitu...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbasi Dezfouli, Saba, Rajendran, Amarnath P., Claerhout, Jillian, Uludag, Hasan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605068/
https://www.ncbi.nlm.nih.gov/pubmed/37892241
http://dx.doi.org/10.3390/biom13101559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605068/
https://www.ncbi.nlm.nih.gov/pubmed/37892241
http://dx.doi.org/10.3390/biom13101559

Ejemplares similares